Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Oncolytic Virus Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncolytic Virus Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncolytic Virus Therapy Overall Market Size
2.1 Global Oncolytic Virus Therapy Market Size: 2021 VS 2028
2.2 Global Oncolytic Virus Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncolytic Virus Therapy Players in Global Market
3.2 Top Global Oncolytic Virus Therapy Companies Ranked by Revenue
3.3 Global Oncolytic Virus Therapy Revenue by Companies
3.4 Top 3 and Top 5 Oncolytic Virus Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oncolytic Virus Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncolytic Virus Therapy Players in Global Market
3.6.1 List of Global Tier 1 Oncolytic Virus Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncolytic Virus Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Oncolytic Virus Therapy Market Size Markets, 2021 & 2028
4.1.2 HSV-based Oncolytic Viruses
4.1.3 Adenoviruses-based Oncolytic Viruses
4.1.4 Vaccinia Virus-based Oncolytic Viruses
4.1.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
4.1.6 Newcastle Disease Virus-based Oncolytic Viruses
4.2 By Type - Global Oncolytic Virus Therapy Revenue & Forecasts
4.2.1 By Type - Global Oncolytic Virus Therapy Revenue, 2017-2022
4.2.2 By Type - Global Oncolytic Virus Therapy Revenue, 2023-2028
4.2.3 By Type - Global Oncolytic Virus Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncolytic Virus Therapy Market Size, 2021 & 2028
5.1.2 Melanoma
5.1.3 Prostate Cancer
5.1.4 Breast Cancer
5.1.5 Ovarian Cancer
5.1.6 Others
5.2 By Application - Global Oncolytic Virus Therapy Revenue & Forecasts
5.2.1 By Application - Global Oncolytic Virus Therapy Revenue, 2017-2022
5.2.2 By Application - Global Oncolytic Virus Therapy Revenue, 2023-2028
5.2.3 By Application - Global Oncolytic Virus Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Oncolytic Virus Therapy Market Size, 2021 & 2028
6.2 By Region - Global Oncolytic Virus Therapy Revenue & Forecasts
6.2.1 By Region - Global Oncolytic Virus Therapy Revenue, 2017-2022
6.2.2 By Region - Global Oncolytic Virus Therapy Revenue, 2023-2028
6.2.3 By Region - Global Oncolytic Virus Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Oncolytic Virus Therapy Revenue, 2017-2028
6.3.2 US Oncolytic Virus Therapy Market Size, 2017-2028
6.3.3 Canada Oncolytic Virus Therapy Market Size, 2017-2028
6.3.4 Mexico Oncolytic Virus Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Oncolytic Virus Therapy Revenue, 2017-2028
6.4.2 Germany Oncolytic Virus Therapy Market Size, 2017-2028
6.4.3 France Oncolytic Virus Therapy Market Size, 2017-2028
6.4.4 U.K. Oncolytic Virus Therapy Market Size, 2017-2028
6.4.5 Italy Oncolytic Virus Therapy Market Size, 2017-2028
6.4.6 Russia Oncolytic Virus Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Oncolytic Virus Therapy Market Size, 2017-2028
6.4.8 Benelux Oncolytic Virus Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Oncolytic Virus Therapy Revenue, 2017-2028
6.5.2 China Oncolytic Virus Therapy Market Size, 2017-2028
6.5.3 Japan Oncolytic Virus Therapy Market Size, 2017-2028
6.5.4 South Korea Oncolytic Virus Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Oncolytic Virus Therapy Market Size, 2017-2028
6.5.6 India Oncolytic Virus Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Oncolytic Virus Therapy Revenue, 2017-2028
6.6.2 Brazil Oncolytic Virus Therapy Market Size, 2017-2028
6.6.3 Argentina Oncolytic Virus Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncolytic Virus Therapy Revenue, 2017-2028
6.7.2 Turkey Oncolytic Virus Therapy Market Size, 2017-2028
6.7.3 Israel Oncolytic Virus Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Oncolytic Virus Therapy Market Size, 2017-2028
6.7.5 UAE Oncolytic Virus Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Oncolytic Virus Therapy Major Product Offerings
7.1.4 Amgen Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.1.5 Amgen Key News
7.2 Oncolytics Biotech
7.2.1 Oncolytics Biotech Corporate Summary
7.2.2 Oncolytics Biotech Business Overview
7.2.3 Oncolytics Biotech Oncolytic Virus Therapy Major Product Offerings
7.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.2.5 Oncolytics Biotech Key News
7.3 Viralytics
7.3.1 Viralytics Corporate Summary
7.3.2 Viralytics Business Overview
7.3.3 Viralytics Oncolytic Virus Therapy Major Product Offerings
7.3.4 Viralytics Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.3.5 Viralytics Key News
7.4 Transgene SA
7.4.1 Transgene SA Corporate Summary
7.4.2 Transgene SA Business Overview
7.4.3 Transgene SA Oncolytic Virus Therapy Major Product Offerings
7.4.4 Transgene SA Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.4.5 Transgene SA Key News
7.5 Oncolys BioPharma
7.5.1 Oncolys BioPharma Corporate Summary
7.5.2 Oncolys BioPharma Business Overview
7.5.3 Oncolys BioPharma Oncolytic Virus Therapy Major Product Offerings
7.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.5.5 Oncolys BioPharma Key News
7.6 Targovax
7.6.1 Targovax Corporate Summary
7.6.2 Targovax Business Overview
7.6.3 Targovax Oncolytic Virus Therapy Major Product Offerings
7.6.4 Targovax Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.6.5 Targovax Key News
7.7 PsiOxus Therapeutics
7.7.1 PsiOxus Therapeutics Corporate Summary
7.7.2 PsiOxus Therapeutics Business Overview
7.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Major Product Offerings
7.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.7.5 PsiOxus Therapeutics Key News
7.8 SillaJen Biotherapeutics
7.8.1 SillaJen Biotherapeutics Corporate Summary
7.8.2 SillaJen Biotherapeutics Business Overview
7.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Major Product Offerings
7.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.8.5 SillaJen Biotherapeutics Key News
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Corporate Summary
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Major Product Offerings
7.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.9.5 Sorrento Therapeutics Key News
7.10 Lokon Pharma
7.10.1 Lokon Pharma Corporate Summary
7.10.2 Lokon Pharma Business Overview
7.10.3 Lokon Pharma Oncolytic Virus Therapy Major Product Offerings
7.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.10.5 Lokon Pharma Key News
7.11 Genelux Corporation
7.11.1 Genelux Corporation Corporate Summary
7.11.2 Genelux Corporation Business Overview
7.11.3 Genelux Corporation Oncolytic Virus Therapy Major Product Offerings
7.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.11.5 Genelux Corporation Key News
7.12 Vyriad
7.12.1 Vyriad Corporate Summary
7.12.2 Vyriad Business Overview
7.12.3 Vyriad Oncolytic Virus Therapy Major Product Offerings
7.12.4 Vyriad Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.12.5 Vyriad Key News
7.13 TILT Biotherapeutics
7.13.1 TILT Biotherapeutics Corporate Summary
7.13.2 TILT Biotherapeutics Business Overview
7.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Major Product Offerings
7.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.13.5 TILT Biotherapeutics Key News
7.14 Cold Genesys
7.14.1 Cold Genesys Corporate Summary
7.14.2 Cold Genesys Business Overview
7.14.3 Cold Genesys Oncolytic Virus Therapy Major Product Offerings
7.14.4 Cold Genesys Oncolytic Virus Therapy Revenue in Global Market (2017-2022)
7.14.5 Cold Genesys Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer